The role of pharmacogenomic testing in psychiatry: Real world examples

@article{Dinama2014TheRO,
  title={The role of pharmacogenomic testing in psychiatry: Real world examples},
  author={Otsile Dinama and Annabelle M Warren and J. Kulkarni},
  journal={Australian & New Zealand Journal of Psychiatry},
  year={2014},
  volume={48},
  pages={778 - 778}
}
  • Otsile Dinama, Annabelle M Warren, J. Kulkarni
  • Published 2014
  • Medicine
  • Australian & New Zealand Journal of Psychiatry
  • Predicting the efficacy, side effects and optimal psychotropic dose for individual patients is a challenge in psychiatry. Current prescribing patterns follow the maxim ‘start low, go slow’. If patients are unresponsive or adverse effects occur, medication is changed. This is time consuming, inefficient and may lead to prolonged illness and financial strain. Patients may experience a sense of hopelessness, and there may be negative impacts on the therapeutic relationship. Pharmacogenomics is the… CONTINUE READING
    Morphine/Codeine Ratio, a Key in Investigating a Case of Doping
    • 9
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-3 OF 3 REFERENCES
    Pharmacogenomics and individualized drug therapy.
    • 567
    • PDF
    Clinical use of pharmacogenomic tests in 2009.
    • 41
    Pharmacogenomics. In: South-Paul JE, Matheny SC and Lewis EL (eds) CURRENT Diagnosis & Treatment in Family Medicine, 3rd edition
    • 2011